)
Visual
test
Qiagen
Qiagen (QGEN) investor relations material
Qiagen Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary5 Feb, 2026
Executive summary
Delivered solid Q4 and FY 2025 results, with net sales and adjusted EPS at or above the high end of outlook ranges, exceeding expectations despite macroeconomic and U.S. government shutdown headwinds.
Growth pillars (Sample technologies, QuantiFERON, QIAstat-Dx, QIAcuity, QIAGEN Digital Insights) achieved $1.49B in sales, up 8% CER, on track for $2B by 2028.
Strategic acquisitions of Parse Biosciences and Genoox expanded the portfolio into single-cell analysis and AI-driven bioinformatics.
Over $1.1B returned to shareholders since 2024, including share repurchases and the first annual dividend.
Mark Stevenson joined the supervisory board; Ross Levine stepped down but remains as scientific advisory board chair.
Financial highlights
FY 2025 net sales: $2.09B (+5% CER); Q4 net sales: $540M (+1% CER), both at the high end of guidance.
Adjusted diluted EPS for FY 2025: $2.40 CER (outlook: $2.38 CER); Q4 adjusted EPS: $0.62 CER.
Adjusted operating income margin expanded to 29.5% in 2025, up 80 bps despite tariff and currency headwinds.
Free cash flow for 2025: $453M, supporting investments and shareholder returns.
Operating cash flow for 2025: $654M, absorbing efficiency initiative payments and higher CAPEX.
Outlook and guidance
2026 outlook: at least 5% CER sales growth and adjusted EPS of at least $2.50 CER.
Q1 2026: net sales growth of at least 1% CER, adjusted EPS of at least $0.54 CER.
Growth pillars targeted to grow ~9% CER in 2026; Sample technologies $720M, QuantiFERON $535M, QIAstat $160M, QIAcuity $100M, QDI $125M.
2028 ambitions reaffirmed: ~7% sales CAGR, at least 31% adjusted operating margin, $2B+ from growth pillars.
Currency expected to have a positive impact on 2026 net sales and neutral impact on adjusted EPS.
How will 2026 margin remain steady despite Parse/tariffs?
Impact of discontinued products ending in 2026?
How do recent acquisitions impact 2026 growth plans?
CEO succession: When to expect an update?
Update on 2028 operating margin target
QIAcuity: Path to $250M by 2028 despite past misses?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebGICRE
Net profit for the nine months surged to ₹6,62,217 lakhs, with a robust solvency ratio of 3.87. - 7 Feb517271
Strong revenue and profit growth, interim dividend, and major investments approved. - 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus.
Next Qiagen earnings date
Leerink Global Healthcare Conference 20269 Mar, 2026
Qiagen
Next Qiagen earnings date
Leerink Global Healthcare Conference 20269 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Qiagen N.V. is a global biotechnology company specializing in sample and assay technologies for molecular diagnostics, life sciences research, and pharmaceutical development. The company provides solutions for DNA, RNA, and protein analysis, serving applications in disease detection, genetic research, and forensic testing. Qiagen’s products include reagents, instruments, and bioinformatics software used by healthcare providers, academic institutions, and biopharmaceutical companies. Qiagen N.V. is headquartered in Venlo, Netherlands, and its shares are listed on the NYSE and the Frankfurt Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage